Potency Assay Considerations for Cartilage Repair, Osteoarthritis and Use of Extracellular Vesicles

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2023 May 31

PMID 37258784

Authors

Lucienne A Vonk

Affiliations

Soon will be listed here.

Abstract

Articular cartilage covers the ends of bones in synovial joints acting as a shock absorber that helps movement of bones. Damage of the articular cartilage needs treatment as it does not repair itself and the damage can progress to osteoarthritis. In osteoarthritis all the joint tissues are involved with characteristic progressive cartilage degradation and inflammation. Autologous chondrocyte implantation is a well-proven cell-based treatment for cartilage defects, but a main downside it that it requires two surgeries. Multipotent, aka mesenchymal stromal cell (MSC)-based cartilage repair has gained attention as it can be used as a one-step treatment. It is proposed that a combination of immunomodulatory and regenerative capacities make MSC attractive for the treatment of osteoarthritis. Furthermore, since part of the paracrine effects of MSCs are attributed to extracellular vesicles (EVs), small membrane enclosed particles secreted by cells, EVs are currently being widely investigated for their potential therapeutic effects. Although MSCs have entered clinical cartilage treatments and EVs are used in in vivo efficacy studies, not much attention has been given to determine their potency and to the development of potency assays. This chapter provides considerations and suggestions for the development of potency assays for the use of MSCs and MSC-EVs for the treatment of cartilage defects and osteoarthritis.

References

Acharya C, Adesida A, Zajac P, Mumme M, Riesle J, Martin I . Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation. J Cell Physiol. 2011; 227(1):88-97. DOI: 10.1002/jcp.22706. View

Adachi N, Ochi M, Deie M, Ito Y . Transplant of mesenchymal stem cells and hydroxyapatite ceramics to treat severe osteochondral damage after septic arthritis of the knee. J Rheumatol. 2005; 32(8):1615-8. View

Bekkers J, Tsuchida A, van Rijen M, Vonk L, Dhert W, Creemers L . Single-stage cell-based cartilage regeneration using a combination of chondrons and mesenchymal stromal cells: comparison with microfracture. Am J Sports Med. 2013; 41(9):2158-66. DOI: 10.1177/0363546513494181. View

Blazquez R, Sanchez-Margallo F, Alvarez V, Uson A, Marinaro F, G Casado J . Fibrin glue mesh fixation combined with mesenchymal stem cells or exosomes modulates the inflammatory reaction in a murine model of incisional hernia. Acta Biomater. 2018; 71:318-329. DOI: 10.1016/j.actbio.2018.02.014. View

Borestrom C, Simonsson S, Enochson L, Bigdeli N, Brantsing C, Ellerstrom C . Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: a first step toward a clinical-grade cell source. Stem Cells Transl Med. 2014; 3(4):433-47. PMC: 3973712. DOI: 10.5966/sctm.2013-0138. View

Bravery C, Carmen J, Fong T, Oprea W, Hoogendoorn K, Woda J . Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry. Cytotherapy. 2012; 15(1):9-19. DOI: 10.1016/j.jcyt.2012.10.008. View

Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L . Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994; 331(14):889-95. DOI: 10.1056/NEJM199410063311401. View

Brittberg M, Recker D, Ilgenfritz J, Saris D . Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Five-Year Follow-up of a Prospective Randomized Trial. Am J Sports Med. 2018; 46(6):1343-1351. DOI: 10.1177/0363546518756976. View

Callahan C, Drake B, Heck D, Dittus R . Patient outcomes following tricompartmental total knee replacement. A meta-analysis. JAMA. 1994; 271(17):1349-57. View

10.

Caplan A, Dennis J . Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006; 98(5):1076-84. DOI: 10.1002/jcb.20886. View

11.

Chahal J, Gomez-Aristizabal A, Shestopaloff K, Bhatt S, Chaboureau A, Fazio A . Bone Marrow Mesenchymal Stromal Cell Treatment in Patients with Osteoarthritis Results in Overall Improvement in Pain and Symptoms and Reduces Synovial Inflammation. Stem Cells Transl Med. 2019; 8(8):746-757. PMC: 6646697. DOI: 10.1002/sctm.18-0183. View

12.

Chen W, Huang Y, Han J, Yu L, Li Y, Lu Z . Immunomodulatory effects of mesenchymal stromal cells-derived exosome. Immunol Res. 2016; 64(4):831-40. DOI: 10.1007/s12026-016-8798-6. View

13.

Chen W, Lai M, Wu A, Wu C, Gelovani J, Lin C . In vitro stage-specific chondrogenesis of mesenchymal stem cells committed to chondrocytes. Arthritis Rheum. 2009; 60(2):450-9. DOI: 10.1002/art.24265. View

14.

Choi H, Lee R, Bazhanov N, Oh J, Prockop D . Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. Blood. 2011; 118(2):330-8. PMC: 3138686. DOI: 10.1182/blood-2010-12-327353. View

15.

Civinini R, Carulli C, Matassi F, Cozzi Lepri A, Sirleo L, Innocenti M . The Survival of Total Knee Arthroplasty: Current Data from Registries on Tribology: Review Article. HSS J. 2017; 13(1):28-31. PMC: 5264570. DOI: 10.1007/s11420-016-9513-9. View

16.

Conforti A, Scarsella M, Starc N, Giorda E, Biagini S, Proia A . Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro. Stem Cells Dev. 2014; 23(21):2591-9. PMC: 4201301. DOI: 10.1089/scd.2014.0091. View

17.

Darling E, Athanasiou K . Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J Orthop Res. 2005; 23(2):425-32. DOI: 10.1016/j.orthres.2004.08.008. View

18.

Davatchi F, Abdollahi B, Mohyeddin M, Nikbin B . Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients. Int J Rheum Dis. 2015; 19(3):219-25. DOI: 10.1111/1756-185X.12670. View

19.

DellAccio F, De Bari C, Luyten F . Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum. 2001; 44(7):1608-19. DOI: 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T. View

20.

Diaz-Romero J, Kursener S, Kohl S, Nesic D . S100B + A1 CELISA: A Novel Potency Assay and Screening Tool for Redifferentiation Stimuli of Human Articular Chondrocytes. J Cell Physiol. 2016; 232(6):1559-1570. DOI: 10.1002/jcp.25682. View